- Article
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience
- Keren Rouvinov,
- Gal Mazor,
- Ella Kozlener,
- Amichay Meirovitz,
- Noa Shani Shrem,
- Omar Abu Saleh,
- Sondos Shalata,
- Alexander Yakobson and
- Walid Shalata
In the treatment of cancer, immune checkpoint inhibitors (ICIs) have demonstrated significantly greater effectiveness compared to conventional cytotoxic or platinum-based chemotherapies. To assess the efficacy of ICI’s in penile squamous cell c...

